FFS was not reached in the Jakafi group compared with 5.7 months in the BAT patients, while 24% showed a greater symptom improvement in the Jakafi group compared with 11% in the BAT group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback